Bulletin from the Annual General Meeting in Hansa Biopharma AB (publ)
Lund, Sweden, June 29, 2023. Hansa Biopharma AB (publ), “Hansa” (Nasdaq Stockholm: HNSA), pioneer in enzyme technology for rare immunological conditions, has today on June 29, 2023 held its Annual General Meeting. The Annual General Meeting was held by physical presence of shareholders and with the option for shareholders to exercise their voting rights by advance voting (postal voting). The Annual General Meeting of Hansa Biopharma AB (publ) (the “Company”) passed the following resolutions. Resolution regarding the adoption of the income statement and the balance sheet as well as